Are European laboratories ready to detect COVID-19?
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
In January 2020, a survey among laboratories to assess the capacity and quality for SARS-CoV-2 (previously 2019-nCoV) diagnostics as well as implementation barriers was conducted. The data provided by 47 laboratories in 30 EU/EEA countries were taken into account in a study released by Eurosurveillance.
The laboratories were asked to indicate their weekly capacity for molecular testing for SARS-CoV-2. Of the 47 participating laboratories, 38 indicated a capacity of minimum 8 275 tests per week.
At the time of the survey, an additional eight laboratories were in the process of implementing molecular diagnostics and these laboratories would, all combined, add a minimum capacity of 875 tests per week once this process would be complete.
Furthermore, the survey indicated a great willingness of laboratories to provide international diagnostic support and to share sequences to contribute to the monitoring of virus evolution and trace transmission chains.
The main challenges for test implementation were an initial lack of positive control, lack of personnel/time and a lack of primers and/or probes.
Read the full assessment
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
Latest updates
Further reading
Surveillance and monitoring
Communicable disease threats report, 4 -11 October 2025, week 41
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 -11 October 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, chikungunya, West Nile virus, dengue, Crimean-Congo haemorrhagic fever, Ebola, measles, and Middle East respiratory syndrome (MERS-CoV).
Surveillance and monitoring
Communicable disease threats report, 27 September - 3 October 2025, week 40
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 September - 3 October 2025 and includes updates on respiratory viruses, SARS-CoV-2, Mpox, rabies, West Nile virus infection, dengue, chikungunya, Crimean-Congo haemorrhagic fever and Ebola.
Surveillance and monitoring
Communicable disease threats report, 30 August - 5 September 2025, week 36
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 August - 5 September 2025 and includes updates on Salmonella Strathcona, West Nile virus infection, dengue, chikungunya, Crimean-Congo haemorrhagic fever, Ebola, MERS-CoV and respiratory viruses.
Surveillance and monitoring
Communicable disease threats report, 2 - 8 August 2025, week 32
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2 - 8 August 2025 and includes updates on influenza A(H5N1), measles, MERS-CoV, respiratory viruses, mass gathering monitoring of the 2025 Jubilee in Italy, Nipah virus disease, Crimean-Congo haemorrhagic fever, dengue, West Nile Virus infection, chikungunya virus disease, and Vibriosis.
Surveillance and monitoring
Communicable disease threats report, 26 July−1 August 2025, week 31
This issue of the CDTR covers the period 26 July−1 August 2025 and includes updates on dengue, mpox, chikungunya virus disease, Crimean-Congo haemorrhagic fever, West Nile Virus, cholera, Botulism, respiratory viruses, avian influenza A(H5N1), SARS-CoV-2, mass gathering monitoring for the Jubilee of 2025 in Italy and mass gathering monitoring for UEFA Women's EURO 2025.